Hyperactivation of PI3K/AKT/mTOR pathway has also been associated with triple-negative breast cancer (TNBC) via loss of phosphatase and tensin homolog (PTEN), a direct counterpart of PI3K (Lopez-Knowles et al., 2010[30]). Here, AKT1 is linked to triple-negative breast carcinoma.